Logo image of AHCO

ADAPTHEALTH CORP (AHCO) Stock Fundamental Analysis

USA - NASDAQ:AHCO - US00653Q1022 - Common Stock

10.67 USD
+1.58 (+17.38%)
Last: 11/4/2025, 8:00:00 PM
10.56 USD
-0.11 (-1.03%)
After Hours: 11/4/2025, 8:00:00 PM
Fundamental Rating

5

AHCO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. While AHCO is still in line with the averages on profitability rating, there are concerns on its financial health. AHCO is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AHCO had positive earnings in the past year.
In the past year AHCO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AHCO reported negative net income in multiple years.
Each year in the past 5 years AHCO had a positive operating cash flow.
AHCO Yearly Net Income VS EBIT VS OCF VS FCFAHCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a Return On Assets value of 1.66%, AHCO perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.73%, AHCO is in the better half of the industry, outperforming 61.00% of the companies in the same industry.
AHCO has a Return On Invested Capital (4.66%) which is comparable to the rest of the industry.
AHCO had an Average Return On Invested Capital over the past 3 years of 4.25%. This is significantly below the industry average of 9.42%.
The last Return On Invested Capital (4.66%) for AHCO is above the 3 year average (4.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.66%
ROE 4.73%
ROIC 4.66%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
AHCO Yearly ROA, ROE, ROICAHCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

AHCO has a Profit Margin of 2.29%. This is in the better half of the industry: AHCO outperforms 62.00% of its industry peers.
In the last couple of years the Profit Margin of AHCO has declined.
AHCO's Operating Margin of 8.10% is fine compared to the rest of the industry. AHCO outperforms 73.00% of its industry peers.
AHCO's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 24.25%, AHCO is in line with its industry, outperforming 49.00% of the companies in the same industry.
In the last couple of years the Gross Margin of AHCO has grown nicely.
Industry RankSector Rank
OM 8.1%
PM (TTM) 2.29%
GM 24.25%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
AHCO Yearly Profit, Operating, Gross MarginsAHCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

AHCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AHCO has been increased compared to 1 year ago.
The number of shares outstanding for AHCO has been increased compared to 5 years ago.
AHCO has a better debt/assets ratio than last year.
AHCO Yearly Shares OutstandingAHCO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AHCO Yearly Total Debt VS Total AssetsAHCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that AHCO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.04, AHCO is not doing good in the industry: 71.00% of the companies in the same industry are doing better.
The Debt to FCF ratio of AHCO is 8.74, which is on the high side as it means it would take AHCO, 8.74 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.74, AHCO is in line with its industry, outperforming 52.00% of the companies in the same industry.
A Debt/Equity ratio of 1.27 is on the high side and indicates that AHCO has dependencies on debt financing.
AHCO's Debt to Equity ratio of 1.27 is on the low side compared to the rest of the industry. AHCO is outperformed by 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 8.74
Altman-Z 1.04
ROIC/WACC0.57
WACC8.23%
AHCO Yearly LT Debt VS Equity VS FCFAHCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

AHCO has a Current Ratio of 1.33. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
AHCO has a Current ratio of 1.33. This is comparable to the rest of the industry: AHCO outperforms 44.00% of its industry peers.
A Quick Ratio of 1.09 indicates that AHCO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, AHCO is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.09
AHCO Yearly Current Assets VS Current LiabilitesAHCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.46% over the past year.
Measured over the past years, AHCO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.23% on average per year.
AHCO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.04%.
The Revenue has been growing by 43.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)122.46%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%-0.7%

3.2 Future

Based on estimates for the next years, AHCO will show a very strong growth in Earnings Per Share. The EPS will grow by 26.56% on average per year.
Based on estimates for the next years, AHCO will show a small growth in Revenue. The Revenue will grow by 7.27% on average per year.
EPS Next Y34.3%
EPS Next 2Y37.99%
EPS Next 3Y31.5%
EPS Next 5Y26.56%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.34%
Revenue Next 5Y7.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AHCO Yearly Revenue VS EstimatesAHCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
AHCO Yearly EPS VS EstimatesAHCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 34.42, the valuation of AHCO can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as AHCO.
AHCO is valuated rather expensively when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.34, the valuation of AHCO can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AHCO indicates a rather cheap valuation: AHCO is cheaper than 92.00% of the companies listed in the same industry.
AHCO is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.42
Fwd PE 9.34
AHCO Price Earnings VS Forward Price EarningsAHCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AHCO is valued cheaper than 92.00% of the companies in the same industry.
AHCO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AHCO is cheaper than 96.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.24
EV/EBITDA 4.98
AHCO Per share dataAHCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AHCO has a very decent profitability rating, which may justify a higher PE ratio.
AHCO's earnings are expected to grow with 31.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y37.99%
EPS Next 3Y31.5%

0

5. Dividend

5.1 Amount

No dividends for AHCO!.
Industry RankSector Rank
Dividend Yield N/A

ADAPTHEALTH CORP

NASDAQ:AHCO (11/4/2025, 8:00:00 PM)

After market: 10.56 -0.11 (-1.03%)

10.67

+1.58 (+17.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners93.9%
Inst Owner Change-0.33%
Ins Owners1.82%
Ins Owner Change1.38%
Market Cap1.44B
Revenue(TTM)3.24B
Net Income(TTM)74.29M
Analysts81.43
Price Target13.26 (24.27%)
Short Float %9.09%
Short Ratio11.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-768.16%
Min EPS beat(2)-1325.49%
Max EPS beat(2)-210.83%
EPS beat(4)1
Avg EPS beat(4)-378.06%
Min EPS beat(4)-1325.49%
Max EPS beat(4)35.5%
EPS beat(8)2
Avg EPS beat(8)-338.41%
EPS beat(12)3
Avg EPS beat(12)-237.75%
EPS beat(16)3
Avg EPS beat(16)-191.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-0.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-0.44%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)7
Avg Revenue beat(16)-0.18%
PT rev (1m)-0.95%
PT rev (3m)0.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.38%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)3.49%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 34.42
Fwd PE 9.34
P/S 0.45
P/FCF 6.24
P/OCF 2.61
P/B 0.92
P/tB N/A
EV/EBITDA 4.98
EPS(TTM)0.31
EY2.91%
EPS(NY)1.14
Fwd EY10.71%
FCF(TTM)1.71
FCFY16.01%
OCF(TTM)4.08
OCFY38.26%
SpS23.95
BVpS11.61
TBVpS-8.94
PEG (NY)1
PEG (5Y)N/A
Graham Number9
Profitability
Industry RankSector Rank
ROA 1.66%
ROE 4.73%
ROCE 6.69%
ROIC 4.66%
ROICexc 4.8%
ROICexgc 17.76%
OM 8.1%
PM (TTM) 2.29%
GM 24.25%
FCFM 7.13%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
ROICexc(3y)4.34%
ROICexc(5y)3.9%
ROICexgc(3y)17.05%
ROICexgc(5y)18.83%
ROCE(3y)6.1%
ROCE(5y)5.39%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y-13.24%
ROICexc growth 3Y18.04%
ROICexc growth 5Y-2.96%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 8.74
Debt/EBITDA 3.16
Cap/Depr 87.27%
Cap/Sales 9.91%
Interest Coverage 2.35
Cash Conversion 87.62%
Profit Quality 311.22%
Current Ratio 1.33
Quick Ratio 1.09
Altman-Z 1.04
F-Score7
WACC8.23%
ROIC/WACC0.57
Cap/Depr(3y)94.46%
Cap/Depr(5y)82.09%
Cap/Sales(3y)11.04%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.46%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y34.3%
EPS Next 2Y37.99%
EPS Next 3Y31.5%
EPS Next 5Y26.56%
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%-0.7%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.34%
Revenue Next 5Y7.27%
EBIT growth 1Y-23.13%
EBIT growth 3Y12.08%
EBIT growth 5Y59.71%
EBIT Next Year170.35%
EBIT Next 3Y49.37%
EBIT Next 5YN/A
FCF growth 1Y960.55%
FCF growth 3Y48.23%
FCF growth 5Y43.24%
OCF growth 1Y28.27%
OCF growth 3Y25.26%
OCF growth 5Y55.08%

ADAPTHEALTH CORP / AHCO FAQ

What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AHCO.


Can you provide the valuation status for ADAPTHEALTH CORP?

ChartMill assigns a valuation rating of 7 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Undervalued.


How profitable is ADAPTHEALTH CORP (AHCO) stock?

ADAPTHEALTH CORP (AHCO) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AHCO stock?

The Price/Earnings (PE) ratio for ADAPTHEALTH CORP (AHCO) is 34.42 and the Price/Book (PB) ratio is 0.92.